Lineage Cell Therapeutics NYSEAMERICAN: LCTX used a conference call to outline its manufacturing strategy and development plans for COR1, a wholly owned preclinical cell transplant program being developed as a potential treatment for corneal endothelial disease.
Lineage remains a Buy, offering a margin of safety and re-rating potential despite near-term macro and operational headwinds. Q1 saw AFFO per share decline 9.3% to $0.78, but guidance for Adj. EBITDA ($1.25–$1.3B) and AFFO per share ($2.75–$3.00) were maintained. LINE's cost reduction plan and automation investments target $110M annualized EBITDA improvement in 3–5 years, supporting long-term upside.
Lineage Logistics faces significant operational and financial risks after two catastrophic fires at major cold storage facilities. Recent fires have led to lawsuits, public health concerns, and potential long-term brand damage, particularly in Los Angeles. Immediate costs include emergency relief and remediation, while longer-term impacts may include higher insurance premiums and increased operating expenses.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 736 | $26,688.52 | $32,816.69 | $6,128.17 | 22.96% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 1 | $32.76 | $44.32 | $11.56 | 35.29% |
| MI Mina Iskander Darlington Partners Capital Management LP | 2.77M | $100.18M | $122.81M | $22.63M | 22.59% |
| YA Yinka Akinsola Blue Trust Inc. | 621 | $22,578.36 | $27,483.6 | $4,905.24 | 21.73% |
Jeffery Yorg Focus Partners Advisor Solutions LLC | 7,139 | $233,873.64 | $316,828.82 | $82,955.18 | 35.47% |
| Industrial REITs Industry | Real Estate Sector | W. Gregory Lehmkuhl CEO | NASDAQ (NGS) Exchange | 53566V106 CUSIP |
| US Country | 24,000 Employees | 30 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Lineage, Inc., a subsidiary of BG Lineage Holdings, LLC, stands as the largest global warehouse real estate investment trust (REIT) specializing in temperature-controlled spaces. Our real estate portfolio, as of March 31, 2024, boasts over 84.1 million square feet (3.0 billion cubic feet of capacity) across 482 warehouses. These strategically located properties span across critical distribution markets with 312 in North America, 82 in Europe, and 88 in Asia-Pacific. Our client base is expansive and diverse, including over 13,000 customers ranging from the biggest names in food retailing, manufacturing, processing, and distribution. Financial performance for the quarter ending March 31, 2024, revealed $1.3 billion in revenue and a net loss of $48.0 million. For the fiscal year 2023, the company achieved $5.3 billion in revenue, with a net loss of $96.2 million. These figures underscore our firm's pivotal role in the global temperature-controlled supply chain, offering unparalleled and technologically advanced solutions to a myriad of customer requirements.
Our portfolio of products and services is designed to meet the diverse and intricate needs of the temperature-controlled supply chain. Each offering is underpinned by our vast global network and cutting-edge technology, ensuring seamless and efficient logistics solutions.